IHEART JAPAN CORP has a total of 14 patent applications. Its first patent ever was published in 2012. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are CELLTRAN LTD, BANC DE SANG I TEIXITS and BIORIGEN S R L.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | United States | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | China | 2 | |
#5 | Republic of Korea | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Object sterilising | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Yamashita Jun | 14 |
#2 | Tabata Yasuhiko | 5 |
#3 | Matsuo Takehiko | 5 |
#4 | Takeda Masafumi | 5 |
#5 | Masumoto Hidetoshi | 2 |
#6 | Ikuno Takeshi | 1 |
#7 | Uosaki Hideki | 1 |
#8 | Matsunaga Taichi | 1 |
Publication | Filing date | Title |
---|---|---|
CN106459922A | Cd82-positive cardiac progenitor cells | |
CN105247041A | Layered cell sheet incorporating hydrogel | |
WO2014192925A1 | Efficient method of deriving endothelial cells | |
EP2826855A1 | Myocardial sheet | |
EP2691513A1 | Novel cardiomyocyte marker |